SCHEMBL9622549

SCHEMBL9622549

N#CC(N)N(C1CCCCC1)C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.38
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2227509 0.73 ADH1C (0.38) FDPS
SCHEMBL15302649 0.69 ADH1A (0.41) FDPS
SCHEMBL2226930 0.68 SHBG (0.35) FDPS
SCHEMBL2230441 0.66 FDPS (0.32) FDPS
Water SCHEMBL5051038 0.65 ADH1A (0.54) FDPS
SCHEMBL28990600 0.65 DPP4 (0.33) DPP4
SCHEMBL15303113 0.64 SHBG (0.39) FDPS
SCHEMBL2292764 0.64 EPHX1 (0.39) DPP4
SCHEMBL16640291 0.64 EPHX1 (0.39) DPP4
SCHEMBL11767385 0.62 ADH1A (0.35) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166166-A Hypotensive agents or treatment of cardiovascular disorders CASSELLA AKTIENGESELLSCHAFT (DE) 1992-11-24 US disclosed
EP-0471232-A1 3-Dicyclohexylamino-sydnonimines, method for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1992-02-19 EP disclosed